Innoviva Total Liabilities and Share Holders Equity 2010-2025 | INVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Innoviva total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Innoviva Total Liabilities and Share Holders Equity 2010-2025 | INVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Innoviva total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$796.4B
Johnson & Johnson (JNJ)	$379.5B
AbbVie (ABBV)	$306B
Novo Nordisk (NVO)	$260.6B
Roche Holding AG (RHHBY)	$248.1B
Novartis AG (NVS)	$234.2B
Merck (MRK)	$196.7B
Sanofi (SNY)	$128.6B
Pfizer (PFE)	$125.6B
Bayer (BAYRY)	$23.7B